The Temperature Controlled Packaging for Pharmaceutical Market rise in need to meet pharmaceutical industry standards to deliver temperature-sensitive products, such as lab samples and vaccines is driving the need for temperature controlled packaging. Market Research Future (MRFR), in its latest report reveals the impact of COVID-19 pandemic on the temperature-controlled packaging market 2020.
Drugs such as, insulin and other used for cancer treatment that require constant temperature control in order to maintain stability can cause the market to surge. MRFR study shows that the world temperature-controlled packaging for pharmaceutical market can thrive at 9.48% CAGR across the study period 2018-2023. The temperature-controlled packaging for pharmaceutical market value can increase from USD 5,116.0 Mn to USD 8,762.4 Mn from 2018 to 2023.
Temperature range, end-use industry, product, type, payload capacity, and type of use are parameters used for the global temperature-controlled packaging for pharmaceutical market segment study.
The product-based segments of the temperature-controlled packaging for pharmaceutical market are insulated containers and insulated shippers. The insulated shippers segment can dominate the market across the review period.
The type-based segments of the global temperature-controlled packaging for pharmaceutical market are passive systems and active systems. The active systems segment can rise at 9.14% CAGR and value at USD 3,587.7 Mn by end of the forecast period.
Get free sample pdf @ https://www.marketresearchfuture.com/sample_request/7190
The temperature range-based segments of the temperature-controlled packaging for pharmaceutical market are 10°C to 20°C, Up to 10°C, and More than 20°C. The up to 10°C segment can value at USD 4,329.4 Mn at 9.93% CAGR in the forecast period.
The payload capacity based segments of the global temperature-controlled packaging for pharmaceutical market are 10-20 L, Up to 10 L, 40-150 L, 20-40 L, and More than 150 L. The up to 10 L segment can value above USD 1,678.4 Mn on the conclusion of the review period. The segment can rise at 9.53% CAGR. The 40-150 L segment is highly growing segment and can rise at 9.88% CAGR in the forecast period.
The type-based segments of the global temperature-controlled packaging for pharmaceutical market are re-usable and single-use. The single-use segment can value above USD 4,549.1 Mn on the conclusion of the review period.
The end-use based segments of the temperature-controlled packaging for pharmaceutical market are clinical trialand pharmaceutical. The pharmaceutical segment can thrive at 10.08% CAGR in the forecast period.
In North America, the temperature-controlled packaging for pharmaceutical product market is observed to hold great potential. Factors that are responsible for the rise of the market in the region are stringent safety policies of pharmaceutical products. The US and Canada can rise at a high pace across the review period.
In Europe, the emerging temperature-controlled packaging for pharmaceutical products market. The introduction of effective goods distribution practices can underline the rise of the market across the review period. The development in novel packaging solutions can cause Europe market to thrive at 9.42% CAGR in the forecast period.
In Asia Pacific, the temperature-controlled packaging for pharmaceutical products market holds several growth prospects. The high investment in R&D rise in pharmaceutical spending by government of different countries of the region can support the expansion of APAC market.
DB Schenker, Sonoco ThermoSafe, Cold Chain Technologies, Sofrigam, United Parcel Service of America, Inc. (UPS), , KUEHNE + NAGEL INC, Softbox Systems Limited DHL International GmbH, Pelican Bio Thermal, Envirotainer AB, Storopack va-Q-tec AG, and Hans Reichenecker GmbH are some notable players in the world temperature-controlled packaging for pharmaceutical market.
Table of Content
1 Executive Summary
2 Market Introduction
2.1 Definition 21
2.2 Scope Of The Study 21
2.3 Market Structure 21
2.4 List Of Assumptions 22
3 Research Methodology
3.1 Research Process 24
3.2 Primary Research 24
3.3 Secondary Research 25
3.4 Market Size Estimation 26
3.5 Forecast Model 27
4 Market Dynamics
4.1 Introduction 29
4.2 Drivers 29
4.2.1 Growth In The Pharmaceutical Industry 29
4.2.2 Adoption Of Smarter Cold Chain Technology 30
4.2.3 Increase In R&D Investment In The Pharmaceutical Industry 30
4.2.4 Drivers Impact Analysis 31
4.3 Restraint 31
4.3.1 Rise In Raw Material Costs 31
4.3.2 Restraint Impact Analysis 32
4.4 Opportunity 32
4.4.1 Balanced Clinical Trial Processes With An Authentic Data System 32
4.4.2 Government Support 32
5 Market Factor Analysis
5.1 Porter’s Five Forces Model 35
5.1.1 Threat Of New Entrants 35
5.1.2 Bargaining Power Of Suppliers 36
5.1.3 Bargaining Power Of Buyers 36
5.1.4 Threat Of Substitutes 36
5.1.5 Rivalry 36
5.2 Supply Chain Analysis 36
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.